Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients. Issue 2 (February 2021)

• Record Type: Journal Article
• Authors: Pereda, Arrate; Elli, Francesca M; Thiele, Suzanne; de Sanctis, Luisa; Rothenbuhler, Anya; Hanna, Patrick; Francou, Bruno; Ertl, Diana Alexandra; Perez de Nanclares, Guiomar; Linglart, Agnès; Mantovani, Giovanna
• Is Part Of: European journal of endocrinology. Volume 184:Issue 2(2021)
• Page Start: 311
• Page End: 320
• Publication Date: 2021-02
• Subjects: Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EJE-20-0625
• Languages: English
• ISSNs: 0804-4643

Abstract

Abstract : Objective: Pseudohypoparathyroidism and related disorders belong to a group of heterogeneous rare diseases that share an impaired signaling downstream of Gsα-protein-coupled receptors. Affected patients may present with various combination of symptoms including resistance to PTH and/or to other hormones, ectopic ossifications, brachydactyly type E, early onset obesity, short stature and cognitive difficulties. Several years ago we proposed a novel nomenclature under the term of inactivating PTH/PTHrP signaling disorders (iPPSD). It is now of utmost importance to validate these criteria and/or improve the basis of this new classification. Design: Retrospective study of a large international series of 459 probands and 85 relatives molecularly characterized. Methods: Information on major and minor criteria associated with iPPSD and genetic results were retrieved from patient files. We compared the presence of each criteria according to the iPPSD subtype, age and gender of the patients. Results: More than 98% of the probands met the proposed criteria for iPPSD classification. Noteworthy, most patients (85%) presented a combination of symptoms rather than a single sign suggestive of iPPSD and the overlap among the different genetic forms of iPPSD was confirmed. The clinical and molecular characterization of relatives identified familial history as an additional important criterion predictive of the disease. Conclusions: The phenotypic analysis of this large cohort confirmed the utility of the major and minor criteria and their combination to diagnose iPPSD. This report shows the importance of having simple and easily recognizable signs to diagnose with confidence these rare disorders and supports a better management of patients.